Molecular Awards

    Congratulations, Dr. Ahmed Ehab!   We are delighted to recognize Dr. Ahmed Ehab with the Innovative Research Award at the International Molecular Biologist Awards for his outstanding contributions to the field of Interventional Pulmonology . Affiliated with DGD Lungenklinik Hemer, Germany , Dr. Ahmed Ehab’s research focuses on advancing respiratory medicine through innovative approaches in bronchoscopy, pulmonary diagnostics, airway management, and minimally invasive lung interventions . His dedication to scientific excellence and clinical research continues to support progress in pulmonary healthcare and inspire the global research community.   Celebrating innovation. Recognizing excellence. Advancing science. Visit : molecularbiologist.org Nomination Link: https://molecularbiologist.org/award-nomination/?ecategory=Awards&rcategory=Awardee Contact Us : info@molecularbiologist.org   26th Edition of International Molecular Biologist Awards | 28–29 Ju...

The International Molecular Biologist Awards recognize outstanding contributions to the field of molecular biology, celebrating individuals and teams pushing the boundaries of biological research. These prestigious awards honor achievements in areas such as genetic engineering, cell biology, genomics, proteomics, bioinformatics, and advancements in molecular diagnostics. Molecular Biologist Awards the Molecular Biologist  Awards, is a premier global event dedicated to the advancement of Molecular Biologist  Awards. This dynamic award has been at the forefront of research, innovation, and collaboration in the ever-evolving field of Molecular Biologist Awards. Website Link: molecularbiologist.org/ Contact Mail ID : support@molecularbiologist.org Nomination Link : https://molecularbiologist.org/award-nomination/?ecategory=Awards&rcategory=Awardee #researchawards #MolecularBiology #Biochemistry #Genetics #Genomics #Biotechnology #CellBiology #Microbiology #Immuno...

  The DNA foundation model Evo 2 has been published in the journal  Nature . Trained on the DNA of over 100,000 species across the entire tree of life, Evo 2 can identify patterns in gene sequences across disparate organisms that experimental researchers would need years to uncover. The machine learning model can accurately identify disease-causing mutations in human genes and is capable of designing new genomes that are as long as the genomes of simple bacteria. Evo 2 was developed by scientists from Arc Institute and NVIDIA, convening collaborators across Stanford University, UC Berkeley, and UC San Francisco. The model's code is publicly accessible from Arc's GitHub, and is also integrated into the NVIDIA BioNeMo framework, as part of a collaboration between Arc Institute and NVIDIA to accelerate scientific research. Arc Institute also worked with AI research lab Goodfire to develop a mechanistic interpretability visualizer that uncovers the key biologic...

  One stem cell generates 14 million tumor-killing natural killer (NK) cells in major cancer breakthrough. Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By engineering early-stage stem cells from cord blood—rather than trying to modify mature natural killer (NK) cells—they created a streamlined process that generates enormous numbers of highly potent NK cells, including CAR-equipped versions designed to hunt specific cancers. NK cells play a critical role in the body’s early defense against viruses and cancer, along with other immune functions. Because of their natural ability to detect and destroy abnormal cells, they are an attractive tool for cancer treatment. In chimeric antigen receptor (CAR)-NK therapy, scientists equip NK cells with a lab-designed receptor (a CAR) so they can recognize a specific marker on cancer cells and attack them more precisely. Traditional CAR-NK approaches usually depend on matur...

  Viral infectious diseases have caused millions of deaths worldwide. Antiviral agents are critical for controlling these infections; however, an open-access database dedicated specifically to antiviral agents remains unavailable. Here, we present AntiviralDB  an expert-curated resource that compiles both approved and experimental antiviral agents with laboratory-confirmed   in vitro   activity against a broad spectrum of human viruses. These include the human immunodeficiency virus, coronaviruses, hepatitis viruses, influenza virus, respiratory syncytial virus, herpes simplex virus, varicella-zoster virus, human cytomegalovirus, human papillomavirus, dengue virus, Zika virus, Ebola virus, mpox virus, norovirus, chikungunya virus, and 16 other common or life-threatening pathogens. Each antiviral agent in the database is annotated with key information, including its molecular target,   in vitro   antiviral activity (IC 50 , EC 50 , and CC 50   across sp...

  Chromothripsis is also surprisingly common. Studies suggest that about one in four cancers shows signs of this type of chromosome damage, and in some cancers the rate is even higher. Nearly all osteosarcomas, an aggressive bone cancer, display evidence of chromothripsis, and many brain cancers show especially elevated levels. "This discovery finally reveals the molecular 'spark' that ignites one of the most aggressive forms of genome rearrangement in cancer," said senior author Don Cleveland, Ph.D., professor of cellular and molecular medicine at UC San Diego School of Medicine and member of UC San Diego Moores Cancer Center. "By finding what breaks the chromosome in the first place, we now have a new and actionable point of intervention for slowing cancer evolution." Chromothripsis begins when errors during cell division trap individual chromosomes inside small, fragile compartments known as micronuclei. When a micronucleus ruptures, the chromosome inside...